ArticleNucleic acids research2025
The nonamer code for RAG-mediated recombination in vivo.
Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
V(D)J recombination, essential for adaptive immunity, is initiated by RAG1/2, which recognizes recombination signal sequences (RSSs) flanking gene segments at antigen receptor loci. RSSs comprise conserved heptamer and nonamer motifs separated by a 12/23-base spacer. While the first three heptamer nucleotides (5'-CAC) are strictly conserved, RSS promiscuity enables RAG "off-target" activity at RSS-like sequences, termed "cryptic RSSs" (cRSSs), contributing to chromosomal deletions and lymphoid tumorigenesis. Notably, the nonamer exhibits substantial sequence variability across physiological RSSs. In addition, many cRSSs lack a discernible nonamer-like sequence, limiting the ability to predict RAG targets based on RSS consensus. Using a high-throughput approach, we characterized here the nonamer properties supporting RAG-mediated recombination. While the consensus nonamer (5'-ACAAAAACC) exhibited strong functionality, numerous sequences significantly different from it promoted a high recombination rate. These functional nonamers balance two, somewhat opposing, features: affinity for the RAG nonamer-binding domain-primarily via a shared purine-A/T-purine motif at positions 4-6-and nucleosome repulsion. Moreover, nonamers of genomic cRSSs mimic canonical nonamers mainly through nucleosome-repelling sequences. This study provides a model for both physiological RAG activity and its off-target effects, enhancing our understanding of immune repertoire formation and the genetic basis of lymphoid cancers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.